Angela Hwang is President, Global Biopharma of PFIZER INC. Currently has a direct ownership of 29,778 shares of PFE, which is worth approximately $833,188. The most recent transaction as insider was on Feb 25, 2023, when has been sold 14,763 shares (Common Stock) at a price of $42.59 per share, resulting in proceeds of $628,756. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.8K
0% 3M change
0% 12M change
Total Value Held $833,188

Angela Hwang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2023
SELL
Payment of exercise price or tax liability
$628,756 $42.59 p/Share
14,763 Reduced 33.14%
29,778 Common Stock
Feb 25 2023
BUY
Exercise of conversion of derivative security
$464,048 $22.89 p/Share
20,273 Added 31.28%
44,541 Common Stock
Feb 22 2023
SELL
Payment of exercise price or tax liability
$1,840,347 $43.04 p/Share
42,759 Reduced 63.79%
24,268 Common Stock
Feb 22 2023
BUY
Exercise of conversion of derivative security
$1,720,655 $30.17 p/Share
57,032 Added 45.97%
67,027 Common Stock
Feb 26 2022
SELL
Payment of exercise price or tax liability
$462,194 $49.18 p/Share
9,398 Reduced 48.46%
9,995 Common Stock
Feb 26 2022
BUY
Exercise of conversion of derivative security
$325,530 $25.6 p/Share
12,716 Added 39.6%
19,393 Common Stock
Feb 23 2022
SELL
Payment of exercise price or tax liability
$720,446 $49.07 p/Share
14,682 Reduced 68.74%
6,677 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
$583,955 $27.34 p/Share
21,359 Added 50.0%
21,359 Common Stock
Nov 12 2021
SELL
Open market or private sale
$1,298,294 $49.61 p/Share
26,170 Reduced 100.0%
1 Common Stock
Feb 27 2021
SELL
Payment of exercise price or tax liability
$273,923 $34.07 p/Share
8,040 Reduced 23.5%
26,171 Common Stock
Feb 27 2021
BUY
Exercise of conversion of derivative security
$220,952 $22.35 p/Share
9,886 Added 22.42%
34,211 Common Stock
Feb 25 2021
SELL
Payment of exercise price or tax liability
$637,863 $34.29 p/Share
18,602 Reduced 43.33%
24,325 Common Stock
Feb 25 2021
BUY
Exercise of conversion of derivative security
$519,283 $22.89 p/Share
22,686 Added 34.58%
42,927 Common Stock
Feb 26 2020
SELL
Payment of exercise price or tax liability
$437,309 $35.76 p/Share
12,229 Reduced 37.66%
20,241 Common Stock
Feb 26 2020
BUY
Exercise of conversion of derivative security
$501,313 $34.59 p/Share
14,493 Added 30.86%
32,470 Common Stock
Feb 23 2020
SELL
Payment of exercise price or tax liability
$50,329 $35.72 p/Share
1,409 Reduced 7.27%
17,977 Common Stock
Feb 27 2019
SELL
Payment of exercise price or tax liability
$473,551 $42.72 p/Share
11,085 Reduced 36.57%
19,230 Common Stock
Feb 27 2019
BUY
Grant, award, or other acquisition
-
6,680 Added 18.06%
30,315 Common Stock
Feb 27 2019
BUY
Exercise of conversion of derivative security
$380,056 $32.23 p/Share
11,792 Added 33.29%
23,635 Common Stock
Feb 25 2019
SELL
Payment of exercise price or tax liability
$67,420 $43.08 p/Share
1,565 Reduced 11.67%
11,843 Common Stock

Also insider at

UPS
UNITED PARCEL SERVICE INC Industrials
AH

Angela Hwang

President, Global Biopharma
New York, NY

Track Institutional and Insider Activities on PFE

Follow PFIZER INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PFE shares.

Notify only if

Insider Trading

Get notified when an Pfizer Inc insider buys or sells PFE shares.

Notify only if

News

Receive news related to PFIZER INC

Track Activities on PFE